BioSig Technologies announced its merger with Streamex on July 8, 2025, securing 1.1 billion USD for commodity tokenization. This pivot from medical technology targets improving liquidity, with a focus on the gold-backed assets within a 142 trillion USD market.
CEO Henry McPhie emphasized on-chain solutions for real-world asset integration, aiming to bring the commodities market onto blockchain platforms. The funding supports BioSig’s ambitions to lead innovation in tokenized commodities.
Leave a Reply